Details of the Active Pharmaceutical Ingredient (API)
General Information of API (ID: D00368) | |||||
---|---|---|---|---|---|
Name |
Liothyronine
|
||||
Synonyms |
Click to Show/Hide the Synonyms of This API
liothyronine; triiodothyronine; 3,3',5-Triiodo-L-thyronine; Liothyronin; 3,5,3'-triiodothyronine; Tresitope; O-(4-Hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine; L-Liothyronine; 3,5,3'-Triiodo-L-thyronine; triothyrone; Liothyroninum; Liotironina; 3,3',5-Triiodothyronine; 3,5,3'TRIIODOTHYRONINE; L-3,5,3'-Triiodothyronine; L-3,3',5-TriioDOThyronine; (2S)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoic acid; (S)-2-amino-3-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)propanoic acid; Triiodo-L-thyronine; CHEBI:18258; L-Tyrosine, O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-; MFCD00002593; CHEMBL1544; UNII-06LU7C9H1V; 4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenylalanine; 06LU7C9H1V; 4-(4-hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine; Lyothyronine; Triiodo-thyroninum; 6893-02-3 (free); 3,3',5-Triiodo-L-thyronine, 95%; L-triiodothyronine; Alanine, 3-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)-, L-; DSSTox_CID_3216; DSSTox_RID_76928; DSSTox_GSID_23216; T3 (amino acid); T3 (Hormone); Triiodothyronine (T3); Liothyronine [INN:BAN]; Alanine, 3-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)-, D- (8CI); Euthroid-1; Euthroid-2; Euthroid-3; Thyrolar-1; Thyrolar-2; Thyrolar-3; Liotironina [INN-Spanish]; CAS-6893-02-3; Euthroid-0.5; Thyrolar-0.5; Liothyronine (INN); T3 (VAN); Thyrolar-0.25; Triiodothyronine, l-; 3,5,3'-Tri-iodo-L-thyronine; SR-05000000455; Liothyroninum [INN-Latin]; Cyronine; NSC-46046; NSC-80203; 3,3',5-Triiodothyronine, L-; HSDB 3110; Prestwick_135; EINECS 229-999-3; NSC 80203; 4-(3-Iodo-4-hydroxyphenoxy)-3,5-diiodophenylalanine; BRN 2710227; PubChem20012; Spectrum_001445; L-3-(4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl)alanine; THYROLAR-5; Prestwick0_000853; Prestwick1_000853; Prestwick2_000853; Prestwick3_000853; Spectrum2_001984; Spectrum3_001887; Spectrum4_000326; Spectrum5_001793; L-Liothyronine; Epitope ID:131324; SCHEMBL8300; NCIStruc1_000449; L-3,3',5-Triiodthyronin; REGID_for_CID_5920; BSPBio_000865; BSPBio_003394; KBioGR_000671; KBioGR_002568; KBioSS_001925; KBioSS_002577; MLS000028458; 3,5,3'-triodo-L-thyronine; SPBio_002167; SPBio_002786; BPBio1_000953; GTPL2634; L-3,3',5-triiodo-Thyronine; 3,3',5-Trichloro-L-thyromine; 3,3\\',5-triiodo-L-thyronine; DTXSID8023216; BCBcMAP01_000192; BDBM18860; HY-A0070A; KBio2_001925; KBio2_002568; KBio2_004493; KBio2_005136; KBio2_007061; KBio2_007704; KBio3_002897; KBio3_003046; (2R)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoic acid; cMAP_000088; HMS1570L07; HMS2097L07; HMS2235A22; HMS3714L07; TRIIODOTHYRONINE (T3 OR LIOTHYRONINE, ACTIVE) (6-11%); ZINC3830999; Tox21_110029; Tox21_301943; ANW-60592; NCGC00013556; 3,5,3'-triiodo-L-thyronine (T3); AKOS016003266; AM83597; CCG-220853; CS-4141; DB00279; SMP1_000179; NCGC00013556-01; NCGC00013556-02; NCGC00013556-03; NCGC00013556-04; NCGC00013556-05; NCGC00013556-15; NCGC00096669-01; NCGC00096669-02; NCGC00255336-01; [125I]T3; AC-31935; AS-17446; SMR000058402; T3; THYROID HORMONE; LIOTHYRONINE; SBI-0206718.P001; DB-021796; 3,3',5-Triiodo-L-thyronine (T3) solution; Thyronine, 3,3',5-triiodo-, L- (6CI); C02465; D08128; Levothyroxine sodium related compound liothyronine; 893T023; O-(4-Hydroxy-3-iodophenyl-3,5-diiodo-L-tyrosine; Q327362; SR-01000003143; SR-01000003143-4; SR-05000000455-2; SR-05000000455-3; BRD-K89152108-001-03-3; 3,3',5-Triiodo-L-thyronine, >=95% (HPLC), powder; Z2216208625; UNII-O48UO55HR0 component AUYYCJSJGJYCDS-LBPRGKRZSA-N; L-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]-Alanine; L-Tyrosine, O-(4-hydroxy-3-iodophenyl)-3,5-diiodo- (9CI); Liothyronine, United States Pharmacopeia (USP) Reference Standard; 3,3',5 Triiodothyronine (T3), IRMM(R) certified Reference Material; O-(4-Hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine, Liothyronine, T3; Liothyronine, Pharmaceutical Secondary Standard; Certified Reference Material
|
||||
Clinical Status |
Approved
|
||||
Disease Indication | Hypothyroidism | ICD-11: 5A00 | [1] | ||
PubChem CID | |||||
Formula |
C15H12I3NO4
|
||||
Canonical SMILES |
C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)O)N)I)I)O
|
||||
InChI |
1S/C15H12I3NO4/c16-9-6-8(1-2-13(9)20)23-14-10(17)3-7(4-11(14)18)5-12(19)15(21)22/h1-4,6,12,20H,5,19H2,(H,21,22)/t12-/m0/s1
|
||||
InChIKey |
AUYYCJSJGJYCDS-LBPRGKRZSA-N
|
||||
Click to Show/Hide the Molecular Data (Structure/Property) of This API | |||||
Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=5920"></iframe>
|
||||
3D MOL | 2D MOL | ||||
Physicochemical Properties | Molecular Weight | 650.97 | Topological Polar Surface Area | 92.8 | |
XlogP | 1.7 | Complexity | 402 | ||
Heavy Atom Count | 23 | Rotatable Bond Count | 5 | ||
Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 5 | ||
Full List of Drug Formulations (DFMs) Containing This API | ||||||
---|---|---|---|---|---|---|
Liothyronine 0.005 mg tablet | Click to Show/Hide the Full List of Formulation(s): 7 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Mannitol; Calcium sulfate dihydrate; Gelatin, unspecified; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Bryant Ranch Prepack | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Mannitol | DIG Info | Glycine receptor alpha-1 (EC50 = 12589.25 nM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Mannitol; Calcium sulfate dihydrate; Gelatin; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Avera McKennan Hospital; Golden State Medical Supply; Sigmapharm Laboratories | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Mannitol | DIG Info | Glycine receptor alpha-1 (EC50 = 12589.25 nM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Calcium sulfate; Sucrose; Talc; Gelatin; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Physicians Total Care | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [4] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Sucrose; Talc; Calcium sulfate anhydrous; Gelatin; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Mylan Pharamceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [4] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Calcium sulfate; Talc; Hypromellose; Silicon dioxide; Cellulose, microcrystalline
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Kaiser Foundation Hospitals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Hypromellose | DIG Info | Cytochrome P450 3A5 (IC50 = 19.4 uM) | [5] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Drug Formulation 6 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Calcium sulfate; Talc; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Aidarex Pharmaceuticals; Carilion Materials Management | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Drug Formulation 7 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Calcium sulfate, unspecified form; Talc; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses
|
|||||
Dosage Form | Oral Tablet | |||||
Company | DirectRX | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Liothyronine 0.025 mg tablet | Click to Show/Hide the Full List of Formulation(s): 8 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Mannitol; Calcium sulfate dihydrate; Gelatin, unspecified; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Bryant Ranch Prepack | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Mannitol | DIG Info | Glycine receptor alpha-1 (EC50 = 12589.25 nM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Mannitol; Calcium sulfate dihydrate; Gelatin; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Avera McKennan Hospital; Golden State Medical Supply; Lake Eire Medical & Surgical Supply DBA Quality Care Products; Sigmapharm Laboratories | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Mannitol | DIG Info | Glycine receptor alpha-1 (EC50 = 12589.25 nM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Calcium sulfate; Sucrose; Talc; Gelatin; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Physicians Total Care | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [4] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Sucrose; Talc; Calcium sulfate anhydrous; Gelatin; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Mylan Pharamceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [4] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Calcium sulfate; Talc; Hypromellose; Silicon dioxide; Cellulose, microcrystalline
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Kaiser Foundation Hospitals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Hypromellose | DIG Info | Cytochrome P450 3A5 (IC50 = 19.4 uM) | [5] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Drug Formulation 6 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Calcium sulfate; Talc; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Carilion Materials Management | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Drug Formulation 7 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Calcium sulfate, unspecified form; Talc; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses
|
|||||
Dosage Form | Oral Tablet | |||||
Company | PD-Rx Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Drug Formulation 8 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Calcium sulfate, unspecified form; Talc; Silicon dioxide; Hypromellose, unspecified; Microcrystalline cellulose
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Bryant Ranch Prepack | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Liothyronine 0.05 mg tablet | Click to Show/Hide the Full List of Formulation(s): 4 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Mannitol; Calcium sulfate dihydrate; Gelatin; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Golden State Medical Supply | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Mannitol | DIG Info | Glycine receptor alpha-1 (EC50 = 12589.25 nM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Sucrose; Talc; Calcium sulfate anhydrous; Gelatin; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Mylan Pharamceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [4] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Calcium sulfate; Talc; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses
|
|||||
Dosage Form | Oral Tablet | |||||
Company | PD-Rx Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Calcium sulfate, unspecified form; Talc; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses
|
|||||
Dosage Form | Oral Tablet | |||||
Company | NuCare Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Liothyronine Sodium 25ug tablet | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Calcium Sulfate Dihydrate; Starch, Corn; Gelatin, Unspecified; Magnesium Stearate; Mannitol
|
|||||
Dosage Form | Tablet | |||||
Company | Bryant Ranch Prepack | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Mannitol | DIG Info | Glycine receptor alpha-1 (EC50 = 12589.25 nM) | [2] | |||
Gelatin | DIG Info | Mephenytoin 4-hydroxylase (EC50 = 20.5 uM) | [5] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Liothyronine Sodium 100mg tablet | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Starch, Corn; Edetate Disodium; Magnesium Stearate; Microcrystalline Cellulose
|
|||||
Dosage Form | Tablet | |||||
Company | Teva Pharmaceuticals Usa | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Liothyronine Sodium 25mg tablet | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Starch, Corn; Edetate Disodium; Magnesium Stearate; Microcrystalline Cellulose
|
|||||
Dosage Form | Tablet | |||||
Company | Teva Pharmaceuticals Usa | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Liothyronine Sodium 5mg tablet | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Starch, Corn; Edetate Disodium; Magnesium Stearate; Microcrystalline Cellulose
|
|||||
Dosage Form | Tablet | |||||
Company | Teva Pharmaceuticals Usa | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.